Meperidine Hydrochloride (Page 4 of 4)

DOSAGE AND ADMINISTRATION

For Relief of Pain

Dosage should be adjusted according to the severity of the pain and the response of the patient. Meperidine is less effective orally than with parenteral administration. The dose of meperidine hydrochloride should be proportionately reduced (usually by 25 to 50 percent) when administered concomitantly with phenothiazines and many other tranquilizers since they potentiate the action of meperidine.

Adults:

The usual dosage is 50 to 150 mg orally every 3 or 4 hours as necessary.

Pediatric Patients:

The usual dosage is 1.1 mg/kg to 1.8 mg/kg orally up to the adult dose, every 3 or 4 hours as necessary.

Each dose of the oral solution should be taken in one-half glass of water, since if taken undiluted, it may exert a slight topical anesthetic effect on mucous membranes.

HOW SUPPLIED

Meperidine Hydrochloride Tablets USP

50 mg white, scored tablets

(Tablets Identified 54 879)

NDC 0054-8595-11: Unit dose, 25 tablets per card (reverse numbered), 1 card per shipper.

NDC 0054-4595-25: Bottles of 100 tablets.

100 mg white, scored tablets

(Tablets Identified 54 163)

NDC 0054-8596-11: Unit dose, 25 tablets per card (reverse numbered), 1 card per shipper.

NDC 0054-4596-25: Bottles of 100 tablets.

Dispense in a well-closed, light-resistant container as defined in the USP/NF.

Meperidine Hydrochloride Oral Solution USP

50 mg per 5 mL (unflavored, colorless oral solution)

NDC 0054-3545-63: Bottles of 500 mL.

DEA Order Form Required.

Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature]

10003964/01

© RLI, 2005

Image from Drug Label Content
MEPERIDINE HYDROCHLORIDE
meperidine hydrochloride solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0054-3545
Route of Administration ORAL DEA Schedule CII
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
meperidine hydrochloride (meperidine) meperidine 50 mg in 5 mL
Inactive Ingredients
Ingredient Name Strength
glycerin
hydrochloric acid
maltol
sodium benzoate
sorbitol solution
water
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0054-3545-63 500 mL (500 MILLILITER) in 1 BOTTLE, PLASTIC None
MEPERIDINE HYDROCHLORIDE
meperidine hydrochloride tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0054-8595
Route of Administration ORAL DEA Schedule CII
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
meperidine hydrochloride (meperidine) meperidine 50 mg
Inactive Ingredients
Ingredient Name Strength
croscarmellose sodium
lactose monohydrate
magnesium stearate
micro-crystalline cellulose
povidone
pregelatinized starch
starch (corn)
Product Characteristics
Color WHITE (WHITE) Score 2 pieces
Shape ROUND (ROUND) Size 7mm
Flavor Imprint Code 54;879
Contains
Coating false Symbol false
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0054-8595-11 25 TABLET (25 TABLET) in 1 BLISTER PACK None
2 NDC:0054-4595-25 100 TABLET (100 TABLET) in 1 BOTTLE, PLASTIC None
MEPERIDINE HYDROCHLORIDE
meperidine hydrochloride tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0054-8596
Route of Administration ORAL DEA Schedule CII
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
meperidine hydrochloride (meperidine) meperidine 100 mg
Inactive Ingredients
Ingredient Name Strength
croscarmellose sodium
lactose monohydrate
magnesium stearate
micro-crystalline cellulose
povidone
pregelatinized starch
starch (corn)
Product Characteristics
Color WHITE (WHITE) Score 2 pieces
Shape ROUND (ROUND) Size 9mm
Flavor Imprint Code 54;163
Contains
Coating false Symbol false
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0054-8596-11 25 TABLET (25 TABLET) in 1 BLISTER PACK None
2 NDC:0054-4596-25 100 TABLET (100 TABLET) in 1 BOTTLE, PLASTIC None
Labeler — Boehringer Ingelheim

Revised: 05/2006 Boehringer Ingelheim

Page 4 of 4 1 2 3 4

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2024. All Rights Reserved.